Zobrazeno 1 - 10
of 27
pro vyhledávání: '"janus kinase 2 V617F mutation"'
Autor:
Mirjam R. Heldner, Diana Aguiar de Sousa, Thalia S. Field, Jonathan M. Coutinho, Susanna M. Zuurbier
Publikováno v:
Frontiers in Neurology, Vol 13 (2022)
Externí odkaz:
https://doaj.org/article/3bc6495afaba408c9fb623b9ef870515
Publikováno v:
Balkan Journal of Medical Genetics, Vol 22, Iss 1, Pp 57-60 (2019)
Myelofibrosis (MF) is characterized by a presence of an extra fibrous tissue in the bone marrow and additional hematopoiesis. The somatic mutation in the Janus kinase 2 (JAK2) gene (V617F) occurs gradually and is detected in about 50.0% of myelofibro
Externí odkaz:
https://doaj.org/article/14dbd66e31384fd2ac81affcdcc2e55a
Publikováno v:
Tzu-Chi Medical Journal, Vol 31, Iss 1, Pp 60-62 (2019)
Polycythemia vera (PV) is relatively uncommon in early adulthood, and evidence about the prevalence of the Janus kinase 2 (JAK2) V617F mutation in the general population is limited. Here, we report a previously healthy volunteer peripheral blood stem
Externí odkaz:
https://doaj.org/article/64593fc44dd44b52a27ec96525909d70
Publikováno v:
Avicenna Journal of Medicine, Vol 07, Iss 01, Pp 28-31 (2017)
Objective: We aimed to investigate the frequency of Janus kinase 2 ( JAK2) mutations in cases with chronic myeloproliferative disorders (CMDs), and the relationship between the presence of JAK2 mutation and leukocytosis and splenomegaly, retrospectiv
Externí odkaz:
https://doaj.org/article/a157274e74a74057940a257df7922f66
Autor:
Shahla′a Fadhil Sabir
Publikováno v:
Iraqi Journal of Hematology, Vol 5, Iss 2, Pp 178-182 (2016)
Background: Myelofibrosis (MF) is largely documented by an abnormal cytokine expression, which in turn could contribute to bone marrow fibrosis, angiogenesis, and constitutional symptoms. To gain additional pathogenetic insight regarding cytokine phe
Externí odkaz:
https://doaj.org/article/c4c3cb4288754ac8bd1976489b8e37f2
Autor:
Mustafa Unubol, Engin Guney, Asli Demirkol, Irfan Yavasoglu, Aykut Soyder, Gökay Bozkurt, Zahit Bolaman
Publikováno v:
Indian Journal of Endocrinology and Metabolism, Vol 17, Iss 1, Pp 153-156 (2013)
Adrenal incidentaloma was detected in an 81-year-old male patient and a 37-year-old female patient who had been diagnosed with essential thrombocytosis. Each patient′s Janus Kinase 2 (JAK2) V617F mutation was positive, and they were evaluated as ha
Externí odkaz:
https://doaj.org/article/018fbf5e79984b3684f3ca0cd05b29cd
Publikováno v:
Balkan Journal of Medical Genetics, Vol 22, Iss 1, Pp 57-60 (2019)
Balkan Journal of Medical Genetics : BJMG
Balkan Journal of Medical Genetics : BJMG
Myelofibrosis (MF) is characterized by a presence of an extra fibrous tissue in the bone marrow and additional hematopoiesis. The somatic mutation in the Janus kinase 2 (JAK2) gene (V617F) occurs gradually and is detected in about 50.0% of myelofibro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::55c1d3787d6e693f1a43cbae03f3be88
https://doaj.org/article/14dbd66e31384fd2ac81affcdcc2e55a
https://doaj.org/article/14dbd66e31384fd2ac81affcdcc2e55a
Publikováno v:
Avicenna Journal of Medicine, Vol 07, Iss 01, Pp 28-31 (2017)
Avicenna Journal of Medicine
Avicenna Journal of Medicine
Objective: We aimed to investigate the frequency of Janus kinase 2 ( JAK2) mutations in cases with chronic myeloproliferative disorders (CMDs), and the relationship between the presence of JAK2 mutation and leukocytosis and splenomegaly, retrospectiv
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3717ecf44a5a51ec035f5ff850ed51e4
https://doi.org/10.4103/2231-0770.197511
https://doi.org/10.4103/2231-0770.197511
Autor:
Li Liu, San‑Yun Wu, Man‑Kai Ju, Meng Sun, Hui Shen, Pan Liu, Liang Shao, Fu‑Ling Zhou, Tingting Huang, Xue‑Lan Zuo, Colin K. He, Yan‑Bo Nie, Yi Zhou, Ying Xu
Publikováno v:
Experimental and Therapeutic Medicine
Essential thrombocythemia (ET) is characterized by thrombotic and hemorrhagic events. The association of clinical characteristics of Chinese ET patients and additional sex combs like 1 (ASXL1) mutations in these patients has remained to be elucidated
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0d1cdec965d1df2726d88341200988f6
https://doi.org/10.3892/etm.2018.5939
https://doi.org/10.3892/etm.2018.5939
Autor:
Shahla'a Fadhil Sabir
Publikováno v:
Iraqi Journal of Hematology, Vol 5, Iss 2, Pp 178-182 (2016)
Background: Myelofibrosis (MF) is largely documented by an abnormal cytokine expression, which in turn could contribute to bone marrow fibrosis, angiogenesis, and constitutional symptoms. To gain additional pathogenetic insight regarding cytokine phe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4edccc3efc27511304ca5c7ee0c9e756
http://www.ijhonline.org/article.asp?issn=2072-8069
http://www.ijhonline.org/article.asp?issn=2072-8069